Massive fatal pulmonary emboli with fibrinolytic therapy.
- 1 November 1981
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 64 (5) , 1068-1069
- https://doi.org/10.1161/01.cir.64.5.1068
Abstract
A [human] case is described in which massive fatal pulmonary emboli followed the initiation of thrombolytic therapy [streptokinase administration]. Several important issues regarding anticoagulation and fibrinolytic therapy are addressed, including the possibility of anticoagulant failure and the risks of using fibrinolytic therapy in the setting of recent and remote thrombotic disease.This publication has 5 references indexed in Scilit:
- Thrombolytic Therapy in Thrombosis: A National Institutes of Health Consensus Development ConferenceAnnals of Internal Medicine, 1980
- The Use of Thrombolytic Agents: Choice of Patient, Drug Administration, Laboratory MonitoringAnnals of Internal Medicine, 1979
- Comparison of Streptokinase with Heparin: Late Results in the Treatment of Deep Venous ThrombosisActa Medica Scandinavica, 1979
- HypertensionCirculation, 1973
- A Prospective Study of the Value of Monitoring Heparin Treatment with the Activated Partial Thromboplastin TimeNew England Journal of Medicine, 1972